Abstract
Following three s.c. injections of acyclovir (100 mg acyclovir/kg) into rats on day 10 of pregnancy 19 litters were evaluated on day 21 of gestation and the effects were compared to the results obtained from controls (nine litters) which received the vehicle (0.1 N NaOH) only. The following results were obtained (treated group versus control group): 1) Implantations/litter: 11.2±1.3 versus 10.2±1.1; 2) resorptions/implantations: 27.7% versus 2.2%; 3) number of viable fetuses evaluated: 154 versus 90; 4) fetuses with anomalies of the skull: 78% versus 12%; 5) fetuses with anomalies of the vertebral column: 38% versus 13%; 6) gross-structural anomalies predominantly affected the skull and tail. The most frequently registered defects were: os tympanicum (smaller): 23%, os tympanicum (missing): 23%; missing tail: 7%; protruding tongue (15%); none of these defects were seen in the control fetuses. Postnatally we observed a high mortality rate among the offspring. From a total of 85 newborn (nine litters) we obtained 73 viable offspring (9.1±3.4); 81% of them had tail alterations. In the control group of eight litters (9.4±2.3) no tail alterations occurred. On day 21 postnatally 40 viable offspring were alive (mortality rate: 38.8%). Nearly all of these animals had visible alterations at multiple sites of their bodies; most frequently observed were: tail impairment, closed eyes, dragging hind-limbs, and urogenital alterations (e.g. testicular atrophy). These studies show for the first time that prenatal treatment with acyclovir induces gross-structural defects which persist postnatally. With the usually applied precautions during therapeutic use in pregnant women, the teratogenic potency of acyclovir seems to be small; however, acyclovir does have a teratogenic potential.
Similar content being viewed by others
References
Adlard BPF, Dobbing J, Sands J (1975) A comparison of the effects of cytosine arabinoside and adenine arabinoside on some aspects of brain growth and development in the rat. Br J Pharmacol 54: 33–39
Bochert G, Rahm U, Schwabe R, Meister R (1987) Plasma concentrations of acyclovir in pregnant fats. Naunyn-Schmiedebergs Arch Pharmacol 335 (Suppl): R29 (Abstract No 116)
Bridgen D, Rosling AE, Woods NC (1982) Renal function after acyclovir intravenous injection. Am J Med 73 (Suppl): 182
Dawson AA (1926) A note on the staining of the skeleton of cleared specimen with alizarin red S. Stain Technol 1: 123–124
DeMiranda P, Whitley RJ, Blum MR, Keeney RE, Barton N, Cocchetto DM, Good S, Hemstreet GP, Kirk LE, Page DA, Elion GB (1979) Acyclovir kinetics after intravenous infusion. Clin Pharmacol Ther 26: 718–728
Elion GB (1982) Mechanism of action and selectivity of acyclovir. Am J Med 73 (Suppl): 7–13
Ferm VH, Willhite C, Kilham L (1978) Teratogenic effects of ribavirin on hamster and rat embryos. Teratology 17: 93–102
Greffe BS, Dooley SL, Deddish RB, Krasny HC (1986) Transplacental passage of acyclovir. J Pediatr 108: 1020–1021
Grover L, Kane J, Kravitz J, Cruz A (1985) Systemic acyclovir in pregnancy: a case report. Obstet Gynecol 65: 284–287
Kasubuchi Y, Wakaizumi S, Shimada M, Nakamura T (1973) Cytosine arabinoside induced microcephaly in mice. Teratology 8: 96
Kingsley S (1986) Acyclovir: foetal and neonatal exposure. 2nd World Congress on Sexually Transmitted Diseases. Paris
Klug S, Lewandowski C, Blankenburg G, Merker H-J, Neubert D (1985) Effect of acyclovir on mammalian embryonic development in culture. Arch Toxicol 58: 89–96
Kochhar DM, Penner JD, Knudsen TB (1980) Embryotoxic, teratogenic, and metabolic effects of ribavirin in mice. Toxicol Appl Pharmacol 52: 99–112
Kurtz SM, Fitzgerald JE, Schardein JL (1977) Comparative animal toxicology of vidarabine and its 5′-monophosphate. Ann NY Acad Sci 284: 6–8
Moore Jr HL, Szczech GM, Rodwell DE, Kapp Jr RW, DeMiranda P, Tucker Jr WE (1983) Preclinical toxicology studies with acyclovir: teratologic, reproductive and neonatal tests. Fund Appl Toxicol 3: 560–568
Neubert D, Chahoud I, Platzek T, Meister R (1987) Principles and problems in assessing prenatal toxicity. Arch Toxicol 60: 238–245
Neubert D, Bochert G, Platzek T, Chahoud I, Fischer B, Meister R (1987b) Dose-response relationship in prenatal toxicity. Congen Anom 27/3: 275–302
Percy DH, Danylchuk KD (1977) Experimental retinal dysplasia due to cytosine arabinoside. Invest Ophthalmol Visual Sci 16: 353–364
Percy DH, Albert DM (1974) Developmental defects in mice and rats treated postnatally with cytosine arabinoside. Exp Molec Pathol 21: 381–397
Percy DH, Albert DM, Amemiya T (1973) Ocular defects in newborn rats treated with 5-iododeoxyuridine (IUDR) (37222). Proc Soc Exp Biol Med 142: 1272–1276
Schardein JL, Hentz DL, Petrere JA, Fitzgerald JE, Kurtz SM (1977) The effect of vidarabine on the development of the offspring of rats, rabbits and monkeys. Teratology 15: 231–242
Skalko RG, Packard DS (1973) The teratogenic response of the mouse embryo to 5-iododesoxyuridine. Experientia 29/2: 198–200
Stahlmann R, Klug S, Lewandowski C, Bochert G, Chahoud I, Rahm U, Merker H-J, Neubert D (1988) Prenatal toxicity of acyclovir in rats. Arch Toxicol (in press)
Stahlmann R, Chahoud I, Bochert G, Neubert D (1987) Teratogenic and postnatal defects in rats after acyclovir application on day 10 of gestation. Teratology 36: 31A
Tucker WE, Macklin AW, Szot RJ, Jonston RE, Elion GB, DeMiranda P, Szczech GM (1983) Preclinical toxicology studies with acyclovir: acute and subchronic tests. Fund Appl Toxicol 3: 573–578
Whiteman PD, Fowle ASE, Burke C, Bye A, Dean K, Fox J, Jeal S (1983) Plasma acyclovir concentration in volunteers after multiple oral doses of acyclovir. 2nd Int. Acyclovir (Zovirax) Symp. (Poster presentations) May 1983, London
Whitley RJ, Alford CA, Hirsch MS, Schooley RT, Luby JP, Aoki FY, Hanley D, Nahmias AJ, Soong S-J (1986) NIAID collaborative antiviral study group. Vidarabine versus acyclovir therapy in herpes simplex encephalitis. NEJ Med 314: 144–149
Whitley R, Alford C, Hess F, Buchanan R (1980) Vidarabine: A preliminary review of its pharmacological properties and therapeutic use. Drugs 20: 267–282
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chahoud, I., Stahlmann, R., Bochert, G. et al. Gross-structural defects in rats after acyclovir application on day 10 of gestation. Arch Toxicol 62, 8–14 (1988). https://doi.org/10.1007/BF00316250
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00316250